144 related articles for article (PubMed ID: 31066068)
1. Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression.
Ma F; Zhu Y; Liu X; Zhou Q; Hong X; Qu C; Feng X; Zhang Y; Ding Q; Zhao J; Hou J; Zhong M; Zhuo H; Zhong L; Ye Z; Xie W; Liu Y; Xiong Y; Chen H; Piao D; Sun B; Gao Z; Li Q; Zhang Z; Qiu X; Zhang Z
Hepatology; 2019 Nov; 70(5):1785-1803. PubMed ID: 31066068
[TBL] [Abstract][Full Text] [Related]
2. UHMK1 promotes gastric cancer progression through reprogramming nucleotide metabolism.
Feng X; Ma D; Zhao J; Song Y; Zhu Y; Zhou Q; Ma F; Liu X; Zhong M; Liu Y; Xiong Y; Qiu X; Zhang Z; Zhang H; Zhao Y; Zhang K; Hong X; Zhang Z
EMBO J; 2020 Mar; 39(5):e102541. PubMed ID: 31975428
[TBL] [Abstract][Full Text] [Related]
3. Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma.
Li W; Yan Y; Zheng Z; Zhu Q; Long Q; Sui S; Luo M; Chen M; Li Y; Hua Y; Deng W; Lai R; Li L
Cell Death Dis; 2020 Nov; 11(11):1011. PubMed ID: 33239622
[TBL] [Abstract][Full Text] [Related]
4. NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2α-ATF4 signalling in breast cancer.
Gupta A; Hossain MM; Miller N; Kerin M; Callagy G; Gupta S
Oncogene; 2016 Nov; 35(45):5860-5871. PubMed ID: 27109102
[TBL] [Abstract][Full Text] [Related]
5. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
[TBL] [Abstract][Full Text] [Related]
6. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
[TBL] [Abstract][Full Text] [Related]
7. Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
Lee YH; Yoon AR; Yun CO; Chung KC
J Biol Chem; 2024 Apr; 300(4):107206. PubMed ID: 38519031
[TBL] [Abstract][Full Text] [Related]
8. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
9. Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function.
Kim K; Lee S; Kang H; Shin E; Kim HY; Youn H; Youn B
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804169
[TBL] [Abstract][Full Text] [Related]
10. DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival.
Li K; Zhao S; Karur V; Wojchowski DM
J Biol Chem; 2002 Dec; 277(49):47052-60. PubMed ID: 12356771
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway.
Zhou B; Lu Q; Liu J; Fan L; Wang Y; Wei W; Wang H; Sun G
Int J Biol Sci; 2019; 15(9):1905-1920. PubMed ID: 31523192
[TBL] [Abstract][Full Text] [Related]
12. Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma.
Zhang Z; Yin J; Zhang C; Liang N; Bai N; Chang A; Liu Y; Li Z; Tan X; Li N; Lv D; Xiang R; Tian Y; Liu C
Cancer Biol Ther; 2012 Apr; 13(6):435-42. PubMed ID: 22338651
[TBL] [Abstract][Full Text] [Related]
13. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN
Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558
[TBL] [Abstract][Full Text] [Related]
14. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
15. MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Zhao JZ; Wang W; Liu T; Zhang L; Lin DZ; Yao JY; Peng X; Jin G; Ma TT; Gao JB; Huang F; Nie J; Lv Q
BMC Cancer; 2022 Dec; 22(1):1290. PubMed ID: 36494680
[TBL] [Abstract][Full Text] [Related]
16. Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.
Tsui YM; Sze KM; Tung EK; Ho DW; Lee TK; Ng IO
Oncotarget; 2017 Jun; 8(24):39430-39442. PubMed ID: 28455968
[TBL] [Abstract][Full Text] [Related]
17. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
18. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J
Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168
[TBL] [Abstract][Full Text] [Related]
19. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
20. DDX3 regulates endoplasmic reticulum stress-induced ATF4 expression.
Adjibade P; Grenier St-Sauveur V; Bergeman J; Huot ME; Khandjian EW; Mazroui R
Sci Rep; 2017 Oct; 7(1):13832. PubMed ID: 29062139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
